Good evening :)
Place Order
Add to Watchlist

Dr. Lal PathLabs Ltd

LALPATHLAB

Dr. Lal PathLabs Ltd

LALPATHLAB
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹19,606 cr, stock is ranked 306
Moderate RiskStock is 2.87x as volatile as Nifty
2,358.402.35% (+54.10)
2,358.402.35% (+54.10)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹19,606 cr, stock is ranked 306
Moderate RiskStock is 2.87x as volatile as Nifty
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹19,606 cr, stock is ranked 306
Moderate RiskStock is 2.87x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
59.4311.540.26%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.965.950.56%

Forecast & Ratings

Detailed Forecast 
29%
Analysts have suggested that investors can buy this stock

from 17 analysts

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Dr Lal Pathlabs Private Limited is headquartered in Gurgaon, Haryana, India and is a medical laboratory operator.

Investor Presentation

View older 

Aug 8, 2023

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Lower than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 13.6%, vs industry avg of 13.8%

Decreasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 3.38% to 3.23%

Loading...

Financial YearFY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023TTM
Total Revenue671.95811.09939.921,088.141,249.371,385.411,632.602,139.962,058.602,237.20
Raw Materialssubtract139.16172.92197.08226.03262.35298.70397.26502.25447.151,592.00
Power & Fuel Costsubtract11.2612.7813.5815.3215.7416.7418.6222.1125.91
Employee Costsubtract134.39136.83152.01180.75208.29242.64273.70364.94376.52
Selling & Administrative Expensessubtract106.64119.68149.29175.89208.79184.69176.29253.82270.25
Operating & Other expensessubtract112.19139.39162.90194.94214.59244.00279.12383.56407.22
Depreciation/Amortizationsubtract28.1928.2827.5433.0638.2272.8177.20108.11150.19144.60
Interest & Other Itemssubtract0.400.500.700.840.8415.3116.0030.1837.5331.80
Taxes & Other Itemssubtract44.0368.5282.2390.59101.3784.56102.79130.15104.98138.90
EPS17.6719.2518.6520.5223.9027.1134.9941.3828.6539.57
DPS1.532.453.004.506.0012.0020.0012.006.0012.00
Payout ratio0.090.130.160.220.250.440.570.290.210.30

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2022

Annual report

PDF

Investor Presentation

May 23PDF
May 17PDF
Feb 10PDF
+2 more
FY 2023

Annual report

PDF

Investor Presentation

May 11PDF
Nov 8PDF
Jul 28PDF
FY 2024

Annual Report Pending

Investor Presentation

Aug 8PDF
Jul 27PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CareHospitals & Diagnostic Centres

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Dr. Lal PathLabs Ltd82.0911.540.26%
Apollo Hospitals Enterprise Ltd112.4614.100.23%
Max Healthcare Institute Ltd76.6611.420.11%
Global Health Ltd115.1415.46

Price Comparison

Compare LALPATHLAB with any stock or ETF
Compare LALPATHLAB with any stock or ETF
LALPATHLAB
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding54.60%5.88%3.68%25.35%10.49%

Mar 2023

Jun 2023

Sep 2023

Dec 2023

Shareholding History

SepDec '22MarJunSepDec '2323.26%25.80%24.89%23.27%24.36%25.35%

Mutual Funds Holding Trend

Mutual Fund Holding

Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

Top 5 Mutual Funds holding Dr. Lal PathLabs Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
UTI Flexi Cap Fund - Growth - Direct Plan

Growth
1.8565%1.49%-0.05%26/67 (-2)
SBI Large & Midcap Fund - Growth - Direct Plan

Growth
0.7502%0.69%0.13%77/91 (+7)
UTI AMC LTD # UTI MF-UTI MID CAP FUND DIRECT PLAN GROWTH PLAN GROWTH

Growth
0.6177%1.21%-0.17%35/96 (-21)

Compare 3-month MF holding change on Screener

Insider Trades & Bulk Deals

Loading...

smallcases

A smallcase is a basket of stocks/ETFs that represents an idea or theme.Diversify your risk and buy smallcases that have Dr. Lal PathLabs Ltd

Events

Dividend Trend

No Trend In Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

LALPATHLAB has shown inconsistent dividend trend over the last 5 years

Dividend Yield

Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 0.26%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹2.55 every year

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateFeb 13, 2024

Interim 2
Interim 2 | Div/Share: ₹12.00

Dividend/Share

12.00

Ex DateEx Date

Feb 13, 2024

Cash Dividend

Ex DateEx DateAug 11, 2023

Interim
Interim | Div/Share: ₹6.00

Dividend/Share

6.00

Ex DateEx Date

Aug 11, 2023

Cash Dividend

Ex DateEx DateAug 11, 2023

Final
Final | Div/Share: ₹6.00

Dividend/Share

6.00

Ex DateEx Date

Aug 11, 2023

Cash Dividend

Ex DateEx DateAug 5, 2022

Interim
Interim | Div/Share: ₹6.00

Dividend/Share

6.00

Ex DateEx Date

Aug 5, 2022

Cash Dividend

Ex DateEx DateJun 22, 2022

Final
Final | Div/Share: ₹6.00

Dividend/Share

6.00

Ex DateEx Date

Jun 22, 2022